Seoul, South Korea

Joo-Hyun Moh

This inventor holds 4 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 3 EPO patents. Top assignee: Amorepacific Corporation. Active years: 2010-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joo-Hyun Moh. Retrieved from https://idiyas.com/inventor/joo-hyun-moh-62vb8pgv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 75.0


 

Average Co-Inventor Count = 14.2

ph-index = 1

Forward Citations = 23(Granted Patents)


Location History:

  • Yongin-si, KR (2011)
  • Seoul, KR (2010 - 2014)

Company Filing History:


Years Active: 2010-2014

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Joo-Hyun Moh: Innovator in Pharmaceutical Compounds

Introduction

Joo-Hyun Moh is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that act as vanilloid receptor antagonists. His work has the potential to impact various medical conditions, providing new avenues for treatment.

Latest Patents

Joo-Hyun Moh holds 4 patents related to novel compounds and their pharmaceutical applications. His latest patents focus on compounds, isomers, or pharmaceutically acceptable salts that serve as vanilloid receptor antagonists. These inventions aim to provide pharmaceutical compositions for preventing or treating a range of diseases, including pain, migraine, arthralgia, neuralgia, neuropathies, and various inflammatory conditions. The innovative nature of his work lies in its potential to address multiple health issues through a single class of compounds.

Career Highlights

Joo-Hyun Moh is associated with Amorepacific Corporation, a leading company in the beauty and health industry. His role at the company allows him to leverage his expertise in pharmaceutical sciences to develop effective treatments that can enhance the quality of life for patients suffering from various ailments.

Collaborations

Throughout his career, Joo-Hyun Moh has collaborated with notable colleagues, including Sun-Young Kim and Byoung Young Woo. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pharmaceutical field.

Conclusion

Joo-Hyun Moh's contributions to pharmaceutical innovations highlight his dedication to improving healthcare through scientific advancements. His work on vanilloid receptor antagonists showcases the potential for new treatments that can address a wide array of medical conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…